← Eichor
Study identifier: NCT07532135 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer

Condition: Healthy Volunteers · Non Diabetic Hyperglycemia  ·  Sponsor: Chulalongkorn University

PhasePhase 1
Planned participants48
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Pornanong Aramwit, Ph.D  ·  +66899217255  ·  aramwit@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

ChulalongkornBangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07532135